|
|
|
DiagRight focuses on last mile connectivity in diagnostic process to reduce scope of errors
|
|
|
|
Top Stories |
|
|
|
|
SME Times News Bureau | 30 Nov, 2021
The Indian diagnostics industry has been evolving at a rapid pace over
the years proving to be one of the crucial components of the healthcare
sector owing to the reliance of the medical professionals on the
diagnostic statement to validate, accurately diagnose ailments and
provide the right treatment.
The presence of more than thousands
of labs and millions of lab technicians yet the industry fails to
suffice and address the need of the consumers as the ecosystem is highly
unorganized and fragmented. According to NCBI (National Centre of
Biotechnology Information) 61.9% of the total lab tests conducted in
India were incorrect. The major contributor is the pre-analytical errors
and logistical challenges associated with sample collection to sample
test in the laboratories.
To address the issues with regards to
analytical errors, channelisation of the last mile delivery and
evaluation of samples, DiagRight, a Gurgaon based health tech startup is
penetrating the market and bringing innovation in the diagnostic
industry with first of its kind hyperlocal model.
Founded in the
year 2020 DiagRight is envisioned to standardize the last mile delivery
and reduce the scope of pre-analytical errors, DiagRight has been
successful in being a changemaker within a year of its operations. The
Co-founder & CEO Asitranjan Biswabhushan clearly demarcates that the
demand for the medical tests is huge whereas the challenge in the
diagnostic ecosystem persists. He also adds that despite the huge demand
for clinical tests there is a lack of supply of trained technicians and
the process is largely non-standardized and unstructured. Thus,
DiagRight claims to be the most promising health-tech start up soon
building an awareness about the diagnostic rights to the citizens of
India.
In order to bridge the gap and address the loops in the
supply and demand DiagRight is strictly adhering with the National
Accreditation Board of Testing & Calibration Laboratories (NABL)
India guidelines and is standardizing the last mile connectivity of the
phlebotomists with the use of technology to minimize the errors in the
diagnostic process. With the increase of relying on the diagnostics to
validate and guide treatment protocols by the doctors 70 per cent of all
the decisions regarding the treatment are completely dependent on the
right diagnosis.
The Co-founder & COO Puneet Sharma says
that "The Home Blood Sample Collection app enables the consumers to
choose any lab within the radius of 10 kms to meet their diagnostic
requirement. The customers have the option to customize their diagnostic
packages by looking into the details of lab pricing for different
tests. All of these are floated to the customers with the option of just
a few clicks on the app by sitting at your home."
The
TrackRight technology developed by DiagRight ensures that the
temperature of the sample is well below 8 degrees Celsius to maintain
the accuracy. The real-time technology also allows the customers to
check the temperature of the sample at any given point of time on the
app. "Samples deposited within 4 hours of collection and tested within a
stipulated time yields the highest accuracy of results" adds Asit.
DiagRight
has partnered with hundreds of labs across India, and the samples are
sent to the nearest possible location to ensure efficacy and minimize
the TAT of the medical reports.
Marking its presence in already
26 cities in India the company has set its goal to expand globally
especially to countries which are deprived of good medical facilities.
"DiagRight promises to contribute significantly to the Universal Health
Coverage (UHC) and ensure good health and well-being across the nation,"
adds Puneet Sharma, COO, DiagRight.
The health-tech start up
not only ensures the right diagnosis for its valued customers but also
adds to the employability of the phlebotomists thus giving them
financial support and grooming them further to enhance their skill in
their dedicated domains.
DiagRight aims to create a niche for
itself by employing more than 2 million phlebotomists in the ensuing
years and being the only company to create the largest fleet of
phlebotomists soon.
|
|
|
|
|
|
|
|
|
|
|
|
|
Customs Exchange Rates |
Currency |
Import |
Export |
US Dollar
|
66.20
|
64.50 |
UK Pound
|
87.50
|
84.65 |
Euro
|
78.25
|
75.65 |
Japanese
Yen |
58.85 |
56.85 |
As on 13 Aug, 2022 |
|
|
Daily Poll |
|
|
PM Modi's recent US visit to redefine India-US bilateral relations |
|
|
|
|
|
Commented Stories |
|
|
|
|
|
|
|
|